Ovid Therapeutics Inc.OVIDNASDAQ

Revenue (LTM)

$7M

+1181.3% YoY

Net Income (LTM)

$-17M

+34.1% YoY

Free Cash Flow

$-38M

Revenue CAGR (5Y)

-10.5%

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	208	2↓99.3%	0↓73.9%	1↑44.4%	7↑1181.3%
Gross Profit	208	2↓99.3%	0↓73.9%	1↑44.4%	7↑1128.3%
Operating Income	124	-56↓144.7%	-59↓6.7%	-62↓4.4%	-42↑31.4%
Net Income	123	-54↓144.1%	-52↑3.4%	-26↑49.5%	-17↑34.1%
EBITDA	124	-54↓143.5%	-57↓5.3%	-58↓1.3%	-42↑26.5%
EPS Diluted	1.76	-0.77↓143.8%	-0.74↑3.9%	-0.37↑50.0%	-0.24↑35.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	188	45↓76.1%	27↓39.7%	26↓2.7%	13↓50.0%
Total Current Assets	190	131↓31.0%	110↓16.6%	56↓49.0%	90↑61.7%
Total Assets	195	155↓20.2%	144↓7.2%	92↓36.0%	151↑63.8%
Total Current Liabilities	15	7↓52.8%	11↑64.1%	11↓8.3%	8↓21.2%
Total Liabilities	15	23↑55.4%	56↑144.6%	24↓57.4%	20↓15.3%
Total Equity	180	132↓26.4%	88↓33.6%	68↓22.3%	131↑91.5%
Total Debt	0	17	16↓3.2%	15↓7.8%	1↓90.3%
Net Debt	-188	-28↑84.9%	-11↑61.0%	-12↓4.6%	-12↓1.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	119	-55↓146.6%	-46↑17.1%	-56↓22.2%	-38↑31.5%
Capital Expenditure	-0	-1↓671.0%	-0↑90.3%	-0↑48.3%	0
Free Cash Flow	118	-57↓147.8%	-46↑18.9%	-56↓22.0%	-38↑31.6%
Stock-Based Comp	0	7	7↑11.1%	6↓13.9%	5↓23.4%
Net Change in Cash	116	-143↓223.5%	-18↑87.5%	-1↑95.8%	-13↓1676.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance